In PDX models of Ewing sarcoma, treatment with the BRD4 inhibitor NHWD870 and the IGF1R inhibitor BMS754807 results in substantial and durable anticancer effects, while monotherapy was much less effective [53]. The gene discussed is IGF1R; the disease is Ewing sarcoma.